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GABAergic pathway was supported by rescue of motor 
symptoms with gabapentin. Interestingly, we observed 
gender specific downregulation of GABA-R and NMDA-R 
expression and reduction in serotonin level. Overexpression 
of hFUS-Q290X also caused an increase in longevity and 
this was accompanied by downregulation of the IIS/TOR 
signalling pathway. Our in vivo studies of the hFUS-Q290X 
mutation in Drosophila link motor dysfunction to impair-
ment in the GABAergic pathway. Our findings would facil-
itate further efforts in unravelling the pathophysiology of 
ET.
Introduction
Essential tremor (ET) is one of the most common adult-
onset, age-progressive neurological disorders, affecting 
about 0.9 % of world population (Louis and Ferreira 2010). 
Despite its high prevalence, the exact pathophysiology of 
ET remains to be elucidated. ET is a heterogeneous disor-
der involving both motor (such as tremor) and non-motor 
(such as cognitive, psychiatric, dementia and sensory) 
symptoms (Chandran and Pal 2012). Unlike in neurode-
generative condition such as PD where there is a progres-
sive loss of dopaminergic neurons (Benazzouz et al. 2014), 
no obvious neuronal loss has been reproducibly observed 
for ET. Neuropathological evidence suggests abnormali-
ties in the GABAergic Purkinje cells of the cerebellum 
and their surrounding neuronal populations which likely 
lead to defects in the cerebellar cortical circuits and output 
(Louis 2016). Higher mortality rates have been reported in 
the cases of late-onset ET (Louis et al. 2007), but increased 
longevity has also been associated with early onset ET and 
observed in ET patients and their relatives (Jankovic et al. 
1995).
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Gene seems to play a major role on the development 
of ET (Jimenez-Jimenez et al. 2013), although the exact 
cause and effect relationship is unclear. This is due to lim-
ited discoveries of pathogenic ET gene mutations and lack 
of in vivo ET models. Pathogenic risk variants have been 
reported for TENM4 (teneurin transmembrane protein 4), 
and studies of this gene in zebra fish suggested its role on 
oligodendrocyte differentiation and myelination of CNS 
axons (Hor et al. 2015). A pathogenic mutation (Q290X) 
has also been recently identified for the FUS/TLS (fused 
in sarcoma/translated in liposarcoma) gene through exome 
sequencing in a large ET family from Quebec (Merner 
et al. 2012). FUS is an RNA/DNA binding protein, and it 
is involved in the regulation of transcription, RNA splicing, 
and translational control (Prasad et al. 1994; Belly et al. 
2005). Q290X is a nonsense mutation caused by a single-
base-pair substitution which results in the truncation of the 
FUS protein at amino acid 290 in its nuclear export signal 
motif (Merner et al. 2012). Mutations in other domains 
of the FUS protein are known to cause amyotrophic lat-
eral sclerosis (ALS) and frontotemporal dementia (FTD) 
(Vance et al. 2009; Chen et al. 2011).
Here, we performed targeted expression analysis (Brand 
and Perrimon 1993) of hFUS-Q290X in Drosophila and 
characterised its phenotype. In addition, we examined the 
involvement of the GABAergic system, the serotonergic 
system, and the IIS/TOR signalling pathway, and con-
ducted therapeutic challenges.
Materials and methods
Drosophila strains and generation of transgenic flies
Flies were raised on standard corn meal containing food 
and genetic crosses were performed at 25 °C. GAL4 lines 
(GMR-GAL4, ple-GAL4, Ddc-GAL4 and OK371-GAL4) 
and RNAi lines to dFUS (stock numbers 32990 and 34839) 
used were obtained from Bloomington Drosophila Stock 
Centre (BDSC). For generation of the wild-type transfor-
mation construct, wild-type hFUS cDNA was excised from 
the pCMV-FUS plasmid DNA (from Origene) using restric-
tion enzymes XhoI and XbaI and subcloned into the XhoI 
and XbaI digested pUAST-attB transformation vector. The 
Q290X mutation was generated using the Quick-Change II 
Site-Directed Mutagensis Kit (Stratagene) following the 
manufacturer’s instructions, with the pUAST-attB-wild-
type hFUS as the DNA template. All plasmid constructs 
which had been subcloned into the transformation vector 
were verified by sequencing before sent for transgenesis at 
Best Gene Inc. To avoid possible contribution of second site 
mutation which might have arisen during transgenesis, the 
transgenic lines were backcrossed into yw (from Bloom-
ington) for six generations.
Western blotting
Proteins were extracted from head homogenates of 
approximately 30–50 flies of the respective genotypes. 
Adult flies were exposed to liquid nitrogen followed by 
shaking to separate the heads from the bodies. Heads were 
collected and homogenised in M-PER Mammalian Pro-
tein Extraction Buffer (Thermo Scientific) in the presence 
of protease inhibitor (Roche). Cell debris was removed 
by centrifugation, and protein concentrations were 
determined by BCA protein assay (Thermo Scientific). 
50–150 µg of total proteins of each samples were dena-
tured by heating to 95 °C and loaded on SDS–PAGE gels. 
After electrophoresis, proteins were transferred to nitro-
cellulose paper, blocked with 1 × PBST + 5 % non-fat 
milk and incubated in primary antibody overnight at 4 °C. 
This was followed by incubation in secondary antibody. 
Protein expression was detected by chemiluminescence 
(Thermo Scientific). Primary antibodies used were rabbit 
anti-FUS (from Bethyl Labs, cat. #A300-302A, 1:1000 
dilution), rabbit anti-N-terminal hFUS (LSC, unpublished 
result, 1:1000), mouse anti-serotonin (Thermo Scientific, 
1:40 dilution), and mouse anti-tubulin (Sigma, 1:10,000 
dilution). Secondary antibodies used were HRP-conju-
gated goat anti-mouse/rabbit (Santa Cruz Biotechnology, 
Inc., 1:4000 dilution).
Immunohistochemistry
Brain fixation and antibody staining were carried out 
according to the standard protocol. Briefly, adult brains 
were dissected in phosphate buffered saline (PBS) then 
fixed with 4 % formaldehyde followed by a few washes 
in PBT (PBS + 0.1 % Triton X-100). After blocking with 
3 % BSA (in PBT), brain samples were incubated in pri-
mary antibody (rabbit anti-tyrosine hydroxylase, Sigma, 
1:1000 dilution) overnight at 4 °C with rotation. After 
removal of primary antibodies, samples were washed 
with PBT followed by incubation in secondary antibody 
(Cy3-conjugated goat anti-rabbit, Jackson Immunore-
search, 1:500). After washes, samples were incubated with 
Vectashield and analysed by Carl Zeiss Upright Confocal 
Microscope.
Light microscopy of adult eyes and wings
For adult eye microscopy, heads were removed and 
glued to masking tapes, and then, photos were captured 
by a digital camera through eye piece of a scanning 
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microscope (Olympus). Photography of wing phenotypes 
was carried out similarly by placing flies on CO2 gas pad 
on their backs.
Longevity and climbing assays
Flies were crossed at 25 °C on standard corn meal contain-
ing food, and at day 1 post-eclosion, males and females 
were separated. Adult flies were aged at 25 °C. Life span 
was scored at a density of 20 flies per vials. Flies were 
transferred to fresh vials thrice a week, followed by scoring 
of dead flies at every transfer. Dead flies were confirmed 
under microscope to assure that they had stopped mov-
ing completely. Locomotion was analysed using negative 
geotaxis assay where approximately 20 flies were left to 
acclimatise to 20-cm height in 1 min. The percentage of 
flies that climbed passed the 20-cm height was recorded. 
For drug treatment, female flies were aged to 10 days, then 
exposed to drug and subjected to negative geotaxis assay. 
Gabapentin (Sigma–Aldrich) was mixed in the food at the 
concentration of 0.1 mg/ml according to the published lit-
erature (Reynolds et al. 2004).
RT‑qPCR
For qPCR, approximately 150–200 fly heads were homog-
enised on ice. Total RNAs were extracted using the RNeasy 
mini kit (Qiagen) according to manufacturer’s instructions. 
Conversion to cDNA was done using High-Capacity Reverse 
Transcription kit (Applied Biosystems), with 1 µg each of 
RNA template. qPCR was carried out using GoTaq® qPCR 
Master Mix (Promega) with the 7500 Fast Real Time Sys-
tem (Applied Biosystems). Primer sequences used to detect 
Drosophila melanogaster mRNA expressions were as follows: 
GABAA-R (Fwd: 5′-GCGAAATTCAGTTCGTGCGT-3′, Rev: 
5′-ACAACGATCAGTCCAGAGGG-3′), GABAB-R (Fwd: 
5′-CAACGACAGCGAGTGTGAG-3′, Rev: 5′-GATGGGT 
GCGGAATAGAGTG-3′), NMDA-R1 (Fwd: 5′-GT 
GGAGCTCTCCAACATGTATC-3′, Rev: 5′-AATCCCAG 
ATGAAGGCCATAAG-3′), NMDA-R2 (Fwd: 5′-TCCTACA 
GCGAGTACGTCTAA-3′, Rev: 5′-CTTTCGCTATCTCGTC 
CCTAAC-3′), 4E-BP (Fwd: 5′-TCAGCTAAGATGTC 
CGCTTC-3′, Rev: 5′-AGATAAGTTTGGTGCCTCCA-3′ 
and atub84b (Fwd: 5′-GATCGTGTCCTCGATTACCGC-3′, 
Rev: 5′-GGGAAGTGAATACGTGGGTAGG-3′). Primer 
sequences used to detect expression of hFUS from transgenes 
were Fwd: 5′-ACGGACACTTCAGGCTATGG-3′ and Rev: 
5′-TACCGTAACTTCCCGAGGTG-3′. Calculation of relative 
gene expression from RT-qPCR experiments was performed 
using the 2(−Delta Delta C(T)) method (Livak and Schmitt-
gen 2001).
Statistical analysis
For all experiments, data from at least two to three biologi-
cal replicates were obtained. For each biological replicate, 
three rounds of technical replicates were conducted. In 
this case, biological replicates involved samples obtained 
from separate batches of genetic crosses which were con-
ducted repeatedly. Technical replicates involved samples 
from same batches of genetic crosses. Negative geotaxis 
assay was analysed by Pearson Chi-square (df = 1) on data 
obtained from three biological replicates. RT-qPCR analy-
sis of FUS mRNA levels was tested using one-way ANOVA 
with Bonferroni post-test for multiple comparisons on data 
obtained from two biological replicates. RT-qPCR analysis 
of GABA-R, NMDA-R, and 4E-BP expression levels was 
tested using one sample Student’s t test (95 % confidence 
interval) on data obtained from three biological replicates. 
Protein band quantification on Western Blot (quantified 
using Image J program) was tested using one sample Stu-
dent’s t test (95 % confidence interval) on data obtained 
from three and five biological replicates (for Western Blot 
results of FUS protein and for Serotonin levels, respec-
tively). Longevity assay was analysed using Kaplan–Meier 
analysis with Cox regression (95 % confidence interval) on 
data obtained from five biological replicates. Software used 
to perform statistical analysis was IBM-SPSS Statistical 
21. Significant differences were defined as P < 0.05.
Results
Phenotypic characterization of hFUS‑Q290X 
in Drosophila
To characterise the phenotypes associated with hFUS-
Q290X mutation, we generated transgenic Drosophila car-
rying hFUS and targeted their expression in different tis-
sues with the versatile binary GAL4/UAS system (Brand 
and Perrimon 1993). The effects of overexpression of 
hFUS-WT and hFUS-Q290X were analysed. As the hFUS-
Q290X mutation has been previously shown to be degraded 
by the nonsense-mediated decay (NMD) pathway, we 
checked mRNA expression of hFUS-WT and hFUS-Q290X 
transgenes using RT-qPCR and found high levels of expres-
sion after 15 days of ageing (Fig. 1a). This was further 
confirmed by intact and similar expression levels of both 
the full length hFUS-WT and the truncated hFUS-Q290X 
proteins (shown on Western Blots, Fig. 1b). Overexpres-
sion of hFUS-WT in the dopaminergic and serotonergic 
systems resulted in the wing-folded phenotype which could 
be partially rescued by reducing the endogenous dFUS 
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expression (Fig. 1c), suggesting conservation of genes and 
pathways between Drosophila and human.
Next, we wanted to analyze motor function in flies 
expressing these transgenes. Although, currently, we do 
not have an assay to measure tremor, we analysed loco-
motion using negative geotaxis (climbing) assay. As tar-
geting expression of other neurodegenerative mutants in 
the dopaminergic and the serotonergic neurons using Ddc-
GAL4 has previously implicated those genes in motility 
(Angeles et al. 2014), we drove our transgenes with this 
driver. Overexpression of hFUS-Q290X resulted in pro-
gressive locomotor impairment (Fig. 2a, shown separately 
for females and males), suggesting a dominant-negative 
mode of action of the Q290X mutation. The observed 
locomotor impairment was not accompanied by obvi-
ous neuronal degeneration as shown by intact DA neu-
rons when hFUS-Q290X was expressed with Ddc-GAL4 
(Fig. 2b, c). Since the presence of degeneration in the 
visual system can be reflected by external rough eye mor-
phology, we expressed hFUS-Q290X in the visual system 
with GMR-GAL4 and found wild-type eye morphology 
(Fig. 2d), suggesting absence of obvious degeneration. 
Impairments in climbing ability and degeneration were 
observed in flies overexpressing hFUS-WT (Fig. 2a–d), 
consistent with the previous reports (Chen et al. 2011; 
Mitchell et al. 2013).
To demonstrate that the observed phenotypes in flies 
overexpressing hFUS- Q290X were not due to toxicity as 
reported when hFUS-WT was overexpressed (Machamer 
et al. 2014), we drove expression of both transgenes with 
OK371-GAL4. We found that while overexpression of 
hFUS-WT resulted in pupal lethality, flies overexpressing 
hFUS-Q290X were viable to the adult stage without obvi-
ous abnormalities (data not shown).
Expression of hFUS‑Q290X results in impairement 
of the GABAergic system
To determine the involvement of the GABAergic system in 
our overexpression study, we performed RT-qPCR analysis 
to check mRNA expression levels of the two major types 
of GABA-R in Drosophila, the ligand-gated ion channel-
type GABAA-R and the metabotropic GABAB-R (Lei et al. 
2013). As the GABAergic transmission has been shown to 
Fig. 1  Expression from the hFUS transgenes and the ability of 
knock down of endogenous dFUS to rescue wing defect caused by 
ectopic expression of hFUS-WT. a RT-qPCR showing mRNA expres-
sion from transgenic lines carrying UAS-hFUS-WT and UAS-hFUS-
Q290X (after 15 days of aging), driven by Ddc-GAL4. The relative 
expression levels of the two transgenes are shown. Note that both 
transgenic lines have similar expression levels. Statistics used is one-
way ANOVA with Bonferroni post-test for multiple comparisons. 
b Western Blot analysis showing protein expression of full-length 
hFUS-WT (around 75 kDa) and truncated hFUS-Q290X (around 
45 kDa) (left and right columns, respectively) under the control of 
GMR-GAL4. Note that although both protein extracts were run on 
the same gel, the blot were divided into two halves to be incubated 
with two different sources of the anti-FUS antibodies. This is due to 
the inability of both antibodies to cross react with the full length and 
the truncated hFUS. Note that the commercial antibody used to detect 
the full length protein does not detect the endogeneous dFUS in the 
control lane (left panel) as it recognises an epitope which maps to a 
region between residues 1 and 50 of hFUS, which is absent in dFUS 
(Stolow and Haynes 1995). The antibody used to detect the truncated 
hFUS protein was generated using a peptide at residues 130–140 
of hFUS. Note that there is one strong band detected at the position 
expected for the truncated FUS protein. Currently, the presence of the 
lighter bands in the control lane (right panel) is still unclear, but those 
are likely to be unspecific signals. c Rescue of wing folded phenotype 
by knock down of endogenous dFUS. Ectopic expression of hFUS-
WT with Ddc-GAL4 results in wing folded phenotype (middle panel). 
This phenotype can be partially rescued by knocking down of endog-
enous dFUS expression (right panel), with either RNAi lines 32990 
or 34839. Note that as compared with the control wings (left panel), 
rescued wings lack shiny appearance of the wild-type wing
▸
1227Hum Genet (2016) 135:1223–1232 
1 3
be regulated by N-methyl-d-aspartate (NMDA) receptor acti-
vation (Xue et al. 2011), we also analysed mRNA expres-
sion level of the two major NMDA-R subunits (NMDA-R1 
and NMDA-R2). Interestingly, not only that overexpression 
of hFUS-Q290X caused a decrease in the mRNA expression 
levels of these receptors (after aging to 15 days), but there 
also seemed to be gender specific differential downregula-
tion of these receptor subunits (Fig. 3a, b). While GABAA-
R was significantly downregulated in males, GABAB-R was 
significantly downregulated in females (Fig. 3a). Simi-
larly, while NMDA-R1 was preferentially downregulated 
in females, NMDA-R2 was preferentially downregulated in 
Fig. 2  Targeted-expression of hFUS-Q290X results in movement 
impairment in the absence of neuronal degeneration. a Negative geo-
taxis assays (of females and males) reflecting locomotor ability of 
flies overexpressing hFUS-Q290X and hFUS-WT under the control 
of Ddc-GAL4. Control flies are Ddc-GAL4/+. Note that flies over-
expressing hFUS-Q290X begins to show climbing impairment after 
10 days of aging and this deteriorates rapidly after 30 and 40 days 
of aging. Overexpression of hFUS-WT starts to cause strong climbing 
impairment after 10 days of aging. Data shown are from three sepa-
rate rounds of experiments (n = 3). Statistics used is Pearson Chi-
square (p value ≤ 0.001 to indicate highly significance as denoted 
by **). b Quantification of DA neuronal clusters in the adult brain 
samples aged to 60 days (for hFUS-Q290X and Control) and to 
40 days (for hFUS-WT). The quantification of DA neuron numbers 
in flies overexpressing hFUS-WT could only be carried out for sam-
ples aged till 40 days, because these flies did not survive to 60 days. 
Note that while reduction in neuronal numbers is significantly present 
in certain DA clusters of flies overexpressing hFUS-WT, there is no 
significant difference in the number of neurons between the control 
flies and the flies overexpressing hFUS-Q290X. Statistics used is 
one-way ANOVA with Bonferroni post-test for multiple comparisons 
(p value ≤0.001 to indicate highly significance as denoted by **; p 
value ≤0.05 to indicate significance as denoted by *). c Representa-
tive pictures showing DA neurons in the adult brain. The genotypes 
are: Ddc-GAL4/+ (control, left column); Ddc-GAL4/UAS-hFUS-WT 
(middle column); and Ddc-GAL4/UAS-hFUS-Q290X (right col-
umn). With the exception of the Ddc-GAL4/UAS-hFUS-WT samples 
which have been aged to 40 days, both the Ddc-GAL4/+ and the 
Ddc-GAL4/UAS-hFUS-Q290X samples have been aged to 60 days. 
Overexpression of hFUS-WT results in reduction of DA neurons; 
however, the number of DA neurons remains normal in flies overex-
pressing hFUS-Q290X. The main clusters of DA neurons examined 
are PAL (paired anterior lateral), PPM1, 2, 3 (paired posterior medial 
clusters 1, 2, and 3), PPL1, 2 (paired posterior lateral clusters 1 and 
2). d Comparison of external structures of the adult ommatidia. Note 
that while overexpression of UAS-hFUS-WT (middle panel) results in 
mild rough eye, overexpression of hFUS-Q290X (right panel) causes 
no sign of degeneration as reflected by wild-type ommatidia similar 
to that seen in the control (GMR-GAL4/+, left panel)
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males (Fig. 3b). It is interesting to note that although over-
expression of hFUS-WT caused a strong locomotion pheno-
type, it did not significantly affect the expression levels of 
these receptors (Fig. 3a, b). This suggests that the observed 
locomotion phenotypes in flies overexpressing hFUS-Q290X 
and hFUS-WT were differentially regulated at the molecular 
level.
To further demonstrate that the impaired GABAer-
gic system contributed to the decline in locomotion, we 
performed rescue experiment with gabapentin. Gabapen-
tin was initially synthesised to mimic GABA and able to 
increase GABA biosynthesis and non-synaptic GABA 
neurotransmission (Kwan et al. 2001), and it is currently 
used in the clinic as one of the treatment options for ET 
(Deuschl et al. 2011). We found that gabapentin was able to 
rescue the locomotion phenotype caused by overexpression 
of hFUS-Q290X (Fig. 3c).
Expression of hFUS‑Q290X results in life span 
extension, downregulation of the insulin/insulin‑like 
growth factor signalling (IIS) pathway and increase 
in serotonin expression
Next, we monitored longevity in our transgenic flies and 
found that while flies overexpressing hFUS-WT had short 
life span (yellow in Fig. 4a–d), flies overexpressing hFUS-
Q290X lived significantly longer. The increase in life span 
was observed when hFUS-Q290X was overexpressed in 
the dopaminergic neurons (green in Fig. 4a, b) and in both 
the dopaminergic and the serotonergic neurons (green in 
Fig. 4c, d). As the insulin/insulin-like growth factor-like 
signalling (IIS) pathway has been implicated in the regula-
tion of life span (Jia et al. 2004), we analysed the expres-
sion of one of the members (4E-BP) in this pathway. Our 
Fig. 3  Expression of hFUS-Q290X causes impairment in the 
GABAergic system. a, b The mRNA expression levels of GABA-R 
and NMDA-R in flies overexpressing hFUS-Q290X and hFUS-WT 
under the control of Ddc-GAL4. Control flies are carrying one copy 
of Ddc-GAL4 alone. All flies have been aged for 15 days before 
mRNA extraction. Results are normalised against the controls. Note 
that while GABAA-R is downregulated in the males, GABAB-R is 
downregulated in the females. Similarly, while NMDA-R1 is prefer-
entially downregulated in the females, NMDA-R2 is preferentially 
downregulated in the males. The levels of GABA-Rs and NMDA-Rs 
are not significantly affected in flies overexpressing hFUS-WT. Sta-
tistical significance of RT-qPCR results is calculated using Student’s 
t test (p < 0.01, as denoted by **). c Rescue of climbing defect of 
female flies overexpressing hFUS-Q290X under the control of Ddc-
GAL4. The ability of gabapentin to rescue the climbing defect is 
monitored for flies which have undergone 20 and 30 days of aging. 
Note that treatment with gabapentin is able to rescue the climbing 
ability of flies overexpressing hFUS-Q290X to very similar degree 
as those observed in the control flies. Statistical analysis was per-
formed using Pearson Chi-square (with p values of 0.008 and 0.009 
as denoted by ** for 20 days and 30 days of aging, respectively)
Fig. 4  Expression of hFUS-Q290X causes increased longevity and 
downregulation of the IIS signalling pathway. a–d Survival curves 
(females and males shown separately) comparing longevity of con-
trol flies (blue in a and b, ple-GAL4/+ or c and d, Ddc-GAL4/+) 
vs. flies overexpressing one copy of UAS-hFUS-Q290X (green) or 
UAS-hFUS–WT (yellow). Note that while overexpression of hFUS–
WT by either driver results in drastic mortality rate (p value ≤0.001), 
expression of hFUS-Q290X (a p value = 0.004; b, p value ≤0.001; 
c p value = 0.015; d p value ≤0.001) causes a significant increase 
in life span as compared with those of controls. The effect on life 
span becomes clearer when flies reached 50–70 days of age. Statis-
tics are performed using Kaplan–Meier analysis with Cox regres-
sion. e RT-qPCR results comparing mRNA levels of 4E-BP in control 
flies vs. flies overexpressing hFUS-Q290X under the control of Ddc-
GAL4 before aging (5 days post eclosion) and after aging (40 days 
post eclosion). Results are normalised against the controls. Note the 
increase in 4E-BP mRNA expression level after 40 days of aging. 
Statistical significance of RT-qPCR results is calculated using Stu-
dent’s t test (p = 0.008). f Western Blotting comparing serotonin level 
in control flies vs. flies overexpressing hFUS-Q290X under the con-
trol of Ddc-GAL4, which has been aged to 15 days. Note the increase 
in serotonin level in flies overexpressing hFUS-Q290X as compared 
with the control. Band quantification is carried out using Image J 
program, and statistical significance is performed using Student’s t 
test (p ≤ 0.001). In all panels, controls are flies carrying one copy of 
Ddc-GAL4 alone
▸
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results showed that while 4E-BP mRNA levels were not 
significantly different in young (5 days old) control flies 
and flies overexpressing hFUS-Q290X, its mRNA level 
was significantly increased in aged flies (40 days) (Fig. 4e), 
indicating downregulation of the IIS signalling pathway.
Serotonin has been known for its roles in controlling the 
GABAergic (Saitow et al. 2009) and the insulin (Luo et al. 
2012) pathways. Using Western Blot analysis, we deter-
mined the level of serotonin and found that overexpression 
of hFUS-Q290X with Ddc-GAL4 resulted in significant 
increase in the serotonin level in female flies (aged 15 days, 
Fig. 4f). Interestingly, the antibody that we used did not 
detect the presence of serotonin in male flies of same age. A 
likely explanation for this is that the antibody we used only 
recognised gender specific form of serotonin. Further exper-
iments with different antibodies to test for gender specificity 
of serotonin changes would be helpful.
Discussions
In this study, we found that despite previous report show-
ing that the hFUS-Q290X truncation mutation was degraded 
by the NMD pathway, we could get stable expression of 
this transcript when expressed in Drosophila. It is likely 
that in ET patients the NMD pathway does not fully sup-
press the residual and possibly deleterious dominant-nega-
tive effect of molecules harbouring premature termination 
codons (PTCs) such as hFUS-Q290X and, hence, resulting 
in disease characteristics. The ability to express the trun-
cated FUS protein enabled us to study its dominant-negative 
effect in Drosophila and revealed some insights on ET dis-
ease pathogenesis.
Our results show that flies overexpressing hFUS-
Q290X had locomotion impairment in the absence of 
obvious degeneration. The locomotion impairment was 
accompanied by downregulation of neurotransmitter 
expression and the ability of rescue by gabapentin. These 
suggest that the hFUS gene may not be required for the 
specification or the maintenance of neurons but may be 
important at the level of neurotransmission. It is impor-
tant to note that decreased levels of GABA-R had been 
observed in postmortem samples from ET individuals 
(Paris-Robidas et al. 2012). The observed gender specific 
effects on downregulation of the GABA-R and NMDA-R 
subunits expression also suggest the possible presence 
of sexual dimorphism in ET disease mechanisms. Sex-
ual dimorphism occurs in both human (Morrow 2015) 
and Drosophila. In Drosophila, the sex difference in 
ethanol sedation has been linked to the expression of a 
gene that regulates splicing of fruitless (fru) (Devineni 
and Heberlein 2012). Male specific FruM isoforms exist 
which regulate sex-specific neural circuits responsible 
for regulating courtship behaviour (Von Philipsborn et al. 
2014). Due to the high conservation of genes and genetic 
pathways in both human and flies, it is possible that lev-
els of serotonin, GABA-R and NMDA-R showed gender 
specific differences in our experimental paradigm. It will 
be interesting to evaluate gender specific differences in 
clinical drug studies as this can provide an explanation 
for inefficient drug therapy or adverse effects which may 
be caused by overactivation of certain pathways in some 
individuals.
Increased longevity has been associated with cases 
of early onset ET. However, the opposite was noted 
in patients having late onset ET, possibly complicated 
by other comorbidities. It is to be noted that the hFUS-
Q290X mutation was identified in patients having early 
onset ET, and our data show that overexpression of hFUS-
Q290X resulted in prolonged life span which was accom-
panied by downregulation of the IIS/TOR signalling path-
way. One of the downstream molecules in the IIS/TOR 
pathway is Forkhead bOX-containing protein, subfamily 
O (FOXO) (Kahn 2015), and a direct target of FOXO is 
4E-BP. Interestingly, FOXO3A genotype has also been 
strongly associated with longevity in human (Willcox 
et al. 2008).
Since serotonin is known for its role in controlling the 
GABAergic and the insulin pathways, it is likely that upstream 
of all the observed phenotypes in our overexpression analysis 
is caused by impairment in the serotonergic pathways. Our 
observation of a possible role of serotonin on the control of 
locomotion is corroborated by studies linking increased extra-
cellular serotonin level to impaired larval locomotion through 
application of drugs that block serotonin transporter (Dasari 
et al. 2007). Further studies will be required to decipher how 
the GABA receptors, and the different serotonin receptors or 
combinations of receptors interact and regulate the resultant 
receptor signalling in FUS-linked ET.
In summary, we demonstrated that Drosophila express-
ing hFUS-Q290X could recapitulate certain characteristics 
found in ET patients such as increased motor dysfunction 
with age, absence of obvious neuronal loss and possibly 
longer life span. These phenotypes were accompanied by 
gender specific reduction in the expression of GABA-R 
and NMDA-R subunits, rescue of the motor dysfunction 
with gabapentin, downregulation of the IIS/TOR signalling 
pathway and increase in serotonin level. Hence, our stud-
ies of hFUS-Q290X in in vivo Drosophila model have shed 
some mechanistic insights on ET pathogenesis. Further 
phenotypic characterization and evaluation of the involved 
molecular mechanisms may lead to improvement of clini-
cal diagnosis and therapy for ET.
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